Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, Larson RA. Churpek JE, et al. Among authors: weiner h. Cancer. 2016 Jan 15;122(2):304-11. doi: 10.1002/cncr.29615. Epub 2015 Dec 7. Cancer. 2016. PMID: 26641009 Free PMC article.
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
Wang AY, Weiner H, Green M, Chang H, Fulton N, Larson RA, Odenike O, Artz AS, Bishop MR, Godley LA, Thirman MJ, Kosuri S, Churpek JE, Curran E, Pettit K, Stock W, Liu H. Wang AY, et al. Among authors: weiner h. J Hematol Oncol. 2018 Jan 5;11(1):4. doi: 10.1186/s13045-017-0550-8. J Hematol Oncol. 2018. PMID: 29304833 Free PMC article. Clinical Trial.
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
Cahill KE, Karimi YH, Karrison TG, Jain N, Green M, Weiner H, Fulton N, Kadri S, Godley LA, Artz AS, Liu H, Thirman MJ, Le Beau MM, McNerney ME, Segal J, Larson RA, Stock W, Odenike O. Cahill KE, et al. Among authors: weiner h. Blood Adv. 2020 Feb 25;4(4):599-606. doi: 10.1182/bloodadvances.2019000795. Blood Adv. 2020. PMID: 32074275 Free PMC article. Clinical Trial.
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
Madero-Marroquin R, Dworkin E, Weiner H, Saygin C, Nawas MT, Drazer MW, DuVall AS, Kosuri S, Thirman MJ, Odenike O, Stock W, Larson RA, Patel AA. Madero-Marroquin R, et al. Among authors: weiner h. Leuk Lymphoma. 2024 Jun;65(6):864-867. doi: 10.1080/10428194.2024.2324991. Epub 2024 Mar 5. Leuk Lymphoma. 2024. PMID: 38441062 No abstract available.
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.
Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, Niu N, Weiner H, Thirman M, Stock W, Smith SM, Nabhan C, Segal JP, Lu P, Wang YL. Kadri S, et al. Among authors: weiner h. Blood Adv. 2017 May 2;1(12):715-727. doi: 10.1182/bloodadvances.2016003632. eCollection 2017 May 9. Blood Adv. 2017. PMID: 29296715 Free PMC article.
Laparotomy-assisted, two-port fetoscopic myelomeningocele repair: infant to preschool outcomes.
Sanz-Cortes M, Whitehead WE, Johnson RM, Aldave G, Castillo H, Desai NK, Donepudi R, Joyeux L, King A, Kralik SF, Lepard J, Mann DG, McClugage SG, Nassr AA, Naus C, Nguyen G, Castillo J, Ravindra VM, Sutton CD, Weiner HL, Belfort MA. Sanz-Cortes M, et al. Among authors: weiner hl. J Neurosurg Pediatr. 2024 Nov 1:1-12. doi: 10.3171/2024.7.PEDS24200. Online ahead of print. J Neurosurg Pediatr. 2024. PMID: 39486058
Spatiotemporal mapping of auditory onsets during speech production.
Kurteff GL, Field AM, Asghar S, Tyler-Kabara EC, Clarke D, Weiner HL, Anderson AE, Watrous AJ, Buchanan RJ, Modur PN, Hamilton LS. Kurteff GL, et al. Among authors: weiner hl. J Neurosci. 2024 Oct 25:e1109242024. doi: 10.1523/JNEUROSCI.1109-24.2024. Online ahead of print. J Neurosci. 2024. PMID: 39455254
1,355 results